A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07K 16/28 (2006.01) C12N 5/20 (2006.01) G01N 33/53 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2391530
Biologically active TR3-specific binding agents and methods for their use are disclosed. The biologically active TR3-specific binding agents are useful for inhibiting the proliferation of cells expressing TR3. These biologically active agents are particularly useful for treating T-cell mediated diseases such as graft-versus-host disease, organ rejection, tumor growth, autoimmunity, and inflammation.
L'invention concerne des agents de liaison biologiquement actifs spécifiques à TR3. Ces agents sont utiles pour inhiber la prolifération de cellules exprimant TR3. Ces agents biologiquement actifs sont particulièrement utiles pour traiter les maladies induites par les lymphocytes T, telles la réaction de greffe contre hôte, le rejet d'organes, la croissance tumorale, l'auto-immunité et l'inflammation.
Tittle Thomas V.
Wegmann Keith W.
Borden Ladner Gervais Llp
Tittle Thomas V.
Wegmann Keith W.
LandOfFree
Tr3-specific binding agents and methods for their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tr3-specific binding agents and methods for their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tr3-specific binding agents and methods for their use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1770373